Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,764 USD | -5,33 % | -3,01 % | +36,81 % |
14/05 | Viracta Therapeutics nomme Michael Faerm directeur financier | MT |
09/05 | Viracta Therapeutics, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 | CI |
Métier
Nombre d'employés: 40
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Mark Rothera
CEO | Chief Executive Officer | 61 | 19/09/22 |
Chief Tech/Sci/R&D Officer | - | - | |
Darrel Cohen
CTO | Chief Tech/Sci/R&D Officer | 59 | 07/08/23 |
Ayman El-Guindy
CTO | Chief Tech/Sci/R&D Officer | - | 06/07/21 |
Ivor Royston
BRD | Director/Board Member | 79 | 01/10/07 |
Ashleigh Barreto
IRC | Investor Relations Contact | - | 01/10/21 |
Melody Burcar
PRN | Corporate Officer/Principal | 41 | 01/09/22 |
Corporate Officer/Principal | - | 06/07/21 | |
Patric Nelson
PRN | Corporate Officer/Principal | - | 06/07/21 |
Cheryl A. Madsen
LAW | General Counsel | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Ivor Royston
BRD | Director/Board Member | 79 | 01/10/07 |
Thomas Darcy
BRD | Director/Board Member | 74 | 01/02/21 |
Barry Simon
BRD | Director/Board Member | 59 | 03/03/21 |
Mark Rothera
CEO | Chief Executive Officer | 61 | 19/09/22 |
Roger Pomerantz
CHM | Chairman | 67 | 01/06/20 |
Flavia Borellini
BRD | Director/Board Member | 64 | 14/08/21 |
Jane Barlow
BRD | Director/Board Member | 63 | 14/08/21 |
Stephen Rubino
BRD | Director/Board Member | 65 | 03/03/21 |
Sam Murphy
BRD | Director/Board Member | 47 | 01/01/19 |
Jane Chung
BRD | Director/Board Member | 53 | 10/08/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 39 272 434 | 38 184 370 ( 97,23 %) | 0 | 97,20 % |
Action B | 0 | 10 248 | 0 | 0 |
Coordonnées société
Viracta Therapeutics, Inc.
2533 South Coast Highway 101 Suite 210
92007, Cardiff
+
http://www.viracta.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+36,81 % | 31,69 M | |
+41,05 % | 54,04 Md | |
+43,57 % | 41,96 Md | |
-1,14 % | 41,92 Md | |
-7,59 % | 28,35 Md | |
+12,16 % | 26,35 Md | |
-22,45 % | 19 Md | |
+7,84 % | 13 Md | |
+29,16 % | 12,28 Md | |
+25,06 % | 12,19 Md |
- Bourse
- Actions
- Action VIRX
- Société Viracta Therapeutics, Inc.